☆ 4.6 Editorial Material

Rethinking treatment for RET-altered lung and thyroid cancers: selpercatinib approval by the EMA

ESMO OPEN (2021)

Get Full Text
Add to Collection

Journal

ESMO OPEN
Volume 6, Issue 1, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.esmoop.2020.100041

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.